About Cleveland HeartLab
Cleveland HeartLab is a Healthcare company based in Cleveland (United States) founded in 2008, and was acquired by Quest Diagnostics in October 2017. Cardiovascular biomarkers are utilized for disease prevention and management. Cleveland HeartLab has raised $38.85 million across 4 funding rounds from investors including Quest Diagnostics, Mutual Capital Partners and Excel Venture Management. Its website clevelandheartlab.com draws about 23 thousand monthly visits. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Screening Devices. Its legal entity is Cleveland HeartLab, Inc. Its competitors include Ionetix, Infraredx and POINT Biomedical; 3 of its 3 listed competitors have raised funding.
Company details
Cleveland HeartLab is a specialty clinical laboratory and disease management company focused on biomarker technologies. Offers a group of biomarkers that provide insight into an individuals risk for cardiovascular diseases. Has developed a profile of tests focused on managing and reducing inflammation along with range of standard and advanced tests. Has one U.S. Food and Drug Administration-approved test that detects an enzyme called myeloperoxidase, or MPO, in the blood.CAP-accredited and CLIA-certified clinical reference laboratory. Covers North America and Europe.
- Headquarters Cleveland, United States
- Stage Acquired
- SectorsHealthcare
- Website clevelandheartlab.com
- Social LinkedIn X Facebook
- Acquired by Quest Diagnostics (Oct 2017)
- Legal Name Cleveland Heartlab, Inc
- Total Equity Funding$38.85M (USD)
in 4 rounds
- Latest Funding Round$2.75M (USD), Series B
Jul 2014
- InvestorsQuest Diagnostics
& 6 more
- Acquired byQuest Diagnostics
(Oct 2017)
Funding Insights of Cleveland HeartLab
Cleveland HeartLab has successfully raised a total of $38.85M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $2.75 million completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $38.85M
- Total Rounds 4
- Last Round Series B — $2.75M
- First Round $3M
(Mar 2010)
- Investors Count 6
All 4 funding rounds of Cleveland HeartLab with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2014 | $2.75M | Series B | – | – | – |
| Oct 2012 | $14.7M | Series B | – | – | |
| Aug 2011 | $18.4M | Series B | – | Excel Venture Management, Healthcare Ventures | – |
| Mar 2010 | $3M | Series A | – | – |
7 investors in total: 7 institutional.
Investors in Cleveland HeartLab
Cleveland HeartLab has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Quest Diagnostics, Mutual Capital Partners and Excel Venture Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| mutualcapitalpartners.com | ||||
Early to late stage VC firm investing in the US | excelvm.com | Boston, United States | ||
| hcven.com | ||||
Second Generation Ltd. is engaged in investment and management activities. | secondgen.com | Cleveland, United States | ||
Zapis Capital Group is involved in capital partnerships. | zapiscapital.com | |||
| glengaryllc.com | ||||
Integrated diagnostic and IT services are provided to healthcare organizations. | 1967 | questdiagnostics.com | Madison, United States |
Investor details for Cleveland HeartLab
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cleveland HeartLab
14 people are tracked at Cleveland HeartLab (4 in leadership, 10 in team).
| Name | Role | Group |
|---|---|---|
Stephen A. Massaro | VP of Sales | Leadership |
Pam Gornall | Vice President and CFO | Leadership |
Ryan McCoy | Director of Product Development | Leadership |
Bill Richendollar | Medical Director, Cleveland HeartLab (Quest Diagnostics) | Leadership |
Jason Lansdale | Marketing Manager | Team |
Emily Hetman | Medical Laboratory Technologist | Team |
Kimberly Cannella | Client Operations Manager | Team |
Todd Hill | Cardiometabolic Sales Executive | Team |
Jayme Baker | Phlebotomist / Lab Technician | Team |
Haiqing Ding | Senior Scientist | Team |
Sarah Allred | Clinical Chemist- Special Chemistry Department | Team |
Sung Pyo | Senior Technical Specialist | Team |
Heather Todd | Client Supply Specialist | Team |
Hydee D. | Cardiometabolic Account Executive | Team |
Complete people profiles for Cleveland HeartLab
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cleveland HeartLab
4 dated milestones of Cleveland HeartLab across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Cleveland HeartLab is founded.
- Funding First funding round of $3.0M.
- Funding Latest funding round, Series B, of $2.8M.
- Exit Acquired by Quest Diagnostics.
Competitors of Cleveland HeartLab
Cleveland HeartLab has 3 listed competitors in our database, 3 of them funded. They include Ionetix, Infraredx and POINT Biomedical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ionetix.com | 2009 | San Francisco, United States | $61.08M | Superconducting cyclotrons for PET radioisotopes are developed by Ionetix. | ||
| infraredx.com | 1998 | Burlington, United States | $99.99M | 59 | Coronary imaging and plaque detection system | |
| pointbio.com | 1996 | San Carlos, United States | $56.4M | Offers a product for cardiologists to conduct myocardial perfusion imaging studies. |
Detailed competitors of Cleveland HeartLab
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cleveland HeartLab
The website of Cleveland HeartLab (clevelandheartlab.com) receives about 23.1K visits a month.
- Monthly visits23.1K
▲ 6.8% vs previous month
Websites whose visitors overlap most with Cleveland HeartLab. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cardiaccarepc.com | cardiaccarepc.com | 100% | #1,058,328 | – | |
unisciencegroup.com | unisciencegroup.com | 94% | – | ||
beaumontlaboratory.com | beaumontlaboratory.com | 93% | #1,546,261 | – | |
etd.paml.com | etd.paml.com | 93% | – | ||
betterhealth.vic.gov.au | betterhealth.vic.gov.au | 87% | #43,466 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 28 similar websites and full traffic analytics for Cleveland HeartLab
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 28 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Cleveland HeartLab (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cleveland Heartlab
Complete news archive for Cleveland HeartLab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cleveland HeartLab
Cleveland HeartLab was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Cleveland HeartLab is headquartered in Cleveland, United States. It is registered at Cleveland, Ohio, United States.
Cleveland HeartLab is a funded company, having raised a total of $38.85M across 4 funding rounds to date. The company's 1st funding round was a Series A of $3M, raised on Mar 2010.
Cleveland HeartLab is a specialty clinical laboratory and disease management company focused on biomarker technologies. Offers a group of biomarkers that provide insight into an individuals risk for cardiovascular diseases. Has developed a profile of tests focused on managing and reducing inflammation along with range of standard and advanced tests. Has one U.S. Food and Drug Administration-approved test that detects an enzyme called myeloperoxidase, or MPO, in the blood.CAP-accredited and CLIA-certified clinical reference laboratory. Covers North America and Europe.
Cleveland HeartLab's top competitors include Infraredx, Ionetix and POINT Biomedical.
Cleveland HeartLab has 7 investors. Key investors include Quest Diagnostics, Mutual Capital Partners, Excel Venture Management, Healthcare Ventures, and Second Generation Ltd.
Cleveland HeartLab operates through Cleveland Heartlab, Inc.
Yes. Cleveland HeartLab was acquired by Quest Diagnostics in October 2017.